| A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia (NCT07686679) | Dong-A ST Co., Ltd. | 2026-08-06 |
| A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects (NCT07633691) | Dong-A ST Co., Ltd. | 2026-06-15 |
| A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma (NCT07481357) | Dong-A ST Co., Ltd. | 2026-05-18 |
| A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R (NCT07513649) | Dong-A ST Co., Ltd. | 2026-04-01 |
| Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State (NCT07342062) | Dong-A ST Co., Ltd. | 2026-01-06 |
| Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State (NCT07297940) | Dong-A ST Co., Ltd. | 2025-12-14 |
| Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects (NCT07239453) | Dong-A ST Co., Ltd. | 2025-11-07 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes (NCT07229534) | Dong-A ST Co., Ltd. | 2025-11-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control (NCT07239440) | Dong-A ST Co., Ltd. | 2025-11-01 |
| A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects (NCT07027982) | Dong-A ST Co., Ltd. | 2025-07-16 |
| Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State (NCT07046715) | Dong-A ST Co., Ltd. | 2025-07-07 |
| A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects (NCT07007533) | Dong-A ST Co., Ltd. | 2025-07-04 |
| Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects (NCT06993181) | Dong-A ST Co., Ltd. | 2025-06-01 |
| To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects (NCT06993168) | Dong-A ST Co., Ltd. | 2025-05-21 |
| The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis (NCT06654856) | Dong-A ST Co., Ltd. | 2024-08-16 |
| A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants (NCT06391827) | Dong-A ST Co., Ltd. | 2024-05-27 |
| Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors (NCT06293651) | Dong-A ST Co., Ltd. | 2024-04-18 |
| Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control (NCT06290349) | Dong-A ST Co., Ltd. | 2024-04-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis (NCT06151210) | Dong-A ST Co., Ltd. | 2024-01-31 |
| Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults (NCT05991401) | Dong-A ST Co., Ltd. | 2023-08-18 |
| Clinical Trial of DA-5212 in Patients with Functional Dyspepsia (NCT05842408) | Dong-A ST Co., Ltd. | 2023-06-06 |
| A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010 (NCT05812417) | Dong-A ST Co., Ltd. | 2023-05-02 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control (NCT05743907) | Dong-A ST Co., Ltd. | 2023-04-25 |
| Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State (NCT05739916) | Dong-A ST Co., Ltd. | 2023-03-30 |
| Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State (NCT05739903) | Dong-A ST Co., Ltd. | 2023-03-25 |
| Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients (NCT05957380) | Dong-A ST Co., Ltd. | 2023-03-20 |
| Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State (NCT05739851) | Dong-A ST Co., Ltd. | 2023-03-18 |
| Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State (NCT05739877) | Dong-A ST Co., Ltd. | 2023-03-17 |
| Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women (NCT05630768) | Dong-A ST Co., Ltd. | 2023-01-03 |
| A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216. (NCT05506007) | Dong-A ST Co., Ltd. | 2022-08-29 |
| Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers (NCT05449704) | Dong-A ST Co., Ltd. | 2022-07-08 |
| A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder (NCT05282069) | Dong-A ST Co., Ltd. | 2022-05-12 |
| Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab" (NCT05376085) | Dong-A ST Co., Ltd. | 2022-05-01 |
| Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects (NCT05106205) | Dong-A ST Co., Ltd. | 2021-12-21 |
| Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers (NCT05132049) | Dong-A ST Co., Ltd. | 2021-12-18 |
| Phase 1 Clinical Trial of DA-5207 in Healthy Adults (NCT05127746) | Dong-A ST Co., Ltd. | 2021-11-25 |
| Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State (NCT05098886) | Dong-A ST Co., Ltd. | 2021-11-07 |
| Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State (NCT05098262) | Dong-A ST Co., Ltd. | 2021-10-31 |
| Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State (NCT05108571) | Dong-A ST Co., Ltd. | 2021-10-28 |
| Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State (NCT05098275) | Dong-A ST Co., Ltd. | 2021-10-26 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects (NCT04906109) | Dong-A ST Co., Ltd. | 2021-07-12 |
| Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811) (NCT04938752) | Dong-A ST Co., Ltd. | 2021-07-08 |
| Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT04785326) | Dong-A ST Co., Ltd. | 2021-04-28 |
| Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature (NCT04798690) | Dong-A ST Co., Ltd. | 2021-02-08 |
| The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects (NCT04686825) | Dong-A ST Co., Ltd. | 2021-01-13 |
| A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg (NCT04653779) | Dong-A ST Co., Ltd. | 2020-12-01 |
| Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab" (NCT04671316) | Dong-A ST Co., Ltd. | 2020-11-23 |
| Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults (NCT04479865) | Dong-A ST Co., Ltd. | 2020-07-28 |
| The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients (NCT04195919) | Dong-A ST Co., Ltd. | 2020-07-10 |
| Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control (NCT04356742) | Dong-A ST Co., Ltd. | 2020-05-26 |
| Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab" (NCT04325009) | Dong-A ST Co., Ltd. | 2020-03-30 |
| Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab. (NCT04326166) | Dong-A ST Co., Ltd. | 2020-03-25 |
| Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control (NCT04170998) | Dong-A ST Co., Ltd. | 2020-01-02 |
| BE Study of Gaster®D Tab 20mg (Manufacturer Changed) (NCT04123899) | Dong-A ST Co., Ltd. | 2019-10-11 |
| Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD (NCT04055883) | Dong-A ST Co., Ltd. | 2019-08-26 |
| Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults (NCT04013477) | Dong-A ST Co., Ltd. | 2019-06-18 |
| Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab" (NCT03932435) | Dong-A ST Co., Ltd. | 2019-04-23 |
| Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases (NCT03910361) | Dong-A ST Co., Ltd. | 2019-04-12 |
| A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State (NCT03944200) | Dong-A ST Co., Ltd. | 2019-02-07 |
| A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State (NCT03939143) | Dong-A ST Co., Ltd. | 2019-02-07 |
| Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults (NCT03766724) | Dong-A ST Co., Ltd. | 2018-11-22 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM (NCT03646721) | Dong-A ST Co., Ltd. | 2018-08-29 |
| Safety and Efficacy of DA-9805 for Parkinson's Disease (NCT03189563) | Dong-A ST Co., Ltd. | 2018-02-06 |
| Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis (NCT03280927) | Dong-A ST Co., Ltd. | 2017-11-10 |